Focusing on the fields of clinical chemistry/immunoassay, coagulation, diabetes and infectious diseases, we conduct R&D of reagents for automated analyzers using enzyme analytical methods and latex immunoturbidimetric methods, as well as columns for diabetes testing based on separation technology with polymer microparticles, and develop clinical diagnostics products with our proprietary technology.

Utilizing our immunoassay, molecular analysis and cell culture technologies, we development for new biomarkers, develop IVD products using highly sensitive immunoassays as well as point-of-care tests in the field of infectious diseases.

Utilizing polymerization, molding, blending and assembly technologies, which are also all core technologies of the Sekisui Chemical Group, we conduct R&D for vacuum blood collection tubes and other related equipment used in the field of pre-analytical IVD process.

We conduct R&D for IVD products in the fields of clinical chemistry, coagulation and infectious diseases that meet the needs of our customers in the US and Europe. Furthermore, clinical trials are conducted in order to introduce Japanese IVD products to US/EU markets.

We develop manufacturing techniques focused on specialty peptides based on our proprietary peptide synthesis technology. We also develop manufacturing processes for investigational drugs through the development and implementation of efficient synthesis methods and purification systems for peptides.

We develop new evaluation systems and related products for biomarkers, etc. in the non-clinical and clinical fields of pharmaceutical development through the use of our pioneering immunoassay, molecular analysis and instrumental analysis technologies.